lasmiditan
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
3 FDA-registered drug labelers
Eli Lilly and Company
Eli Lilly Kinsale Limited
Lilly del Caribe, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Reyvow
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Lasmiditan Succinate Tablet
11/03/2025Chemical Identity
CAS439239-90-4
PubChem CID11610526
DTXSIDDTXSID40469435
FormulaC19H18F3N3O2
Mol. Weight377.4 g/mol
SMILESCN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F
Data Sources
116105262026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/lasmiditan/cids/JSON
Archive: data/sources/pubchem_name/lasmiditan.json
CAS 439239-90-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 439239-90-42026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json